CoChat

Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus—Learnings for Designing Novel Therapeutics

Badarau, Adriana, Trstenjak, Nikolina, Nagy, Eszter · 2017 · Advances in Experimental Medicine and Biology
Cited by 20

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/5584_2016_200

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 55

  1. Adhikari RP, Kort T, Shulenin S, Kanipakala T, Ganjbaksh N, Roghmann MC, Holtsberg FW, Aman MJ (2015) Antibodies to S. aureus LukS-PV attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs. PLoS One 10:e0137874 · DOI
  2. Alonzo F 3rd, Torres VJ (2014) The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev 78:199–230 · DOI · Paper page
  3. Badarau A, Rouha H, Malafa S, Logan DT, Håkansson M, Stulik L, Dolezilkova I, Teubenbacher A, Gross K, Maierhofer B, Weber S, Jägerhofer M, Hoffman D, Nagy E (2015) Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH. J Biol Chem 290:142–156 · DOI
  4. Badarau A, Rouha H, Malafa S, Battles MB, Walker L, Nielson N, Dolezilkova I, Teubenbacher A, Banerjee S, Maierhofer B, Weber S, Stulik L, Logan DT, Welin M, Mirkina I, Pleban C, Zauner G, Gross K, Jägerhofer M, Magyarics Z, Nagy E (2016) Context matters: the importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. MAbs 8:1347–1360 · DOI · Paper page
  5. Berube BJ, Bubeck Wardenburg J (2013) Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) 5:1140–1166 · DOI · Paper page
  6. Dal Peraro M, van der Goot FG (2016) Pore-forming toxins: ancient, but never really out of fashion. Nat Rev Microbiol 14:77–92 · DOI · Paper page
  7. Dalla Serra M, Coraiola M, Viero G, Comai M, Potrich C, Ferreras M, Baba-Moussa L, Colin DA, Menestrina G, Bhakdi S, Prévost G (2005) Staphylococcus aureus bicomponent gamma-hemolysins, HlgA, HlgB, and HlgC, can form mixed pores containing all components. J Chem Inf Model 45:1539–1545 · DOI
  8. Diep BA, Le VTM, Visram ZC, Rouha H, Stulik L, Dip EC, Nagy G, Nagy E (2016) Improved protection in a rabbit model of CA-MRSA necrotizing pneumonia upon neutralization of leukocidins in addition to alpha-hemolysin. Antimicrob Agents Chemother 60:6333–6340 · DOI
  9. Dong J, Qiu J, Zhang Y, Lu C, Dai X, Wang J, Li H, Wang X, Tan W, Luo M, Niu X, Deng X (2013) Oroxylin A Inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. In: Livesay DR (ed) PLoS Comput Biol 9:e1002869 · DOI
  10. Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A, Nagy E (2005) Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol 12:387–398 · DOI · Paper page
  11. DuMont AL, Yoong P, Liu X, Day CJ, Chumbler NM, James DBA, Alonzo F, Bode NJ, Lacy DB, Jennings MP, Torres VJ (2014) Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect Immun 82:1268–1276 · DOI
  12. Fiaschi L, Di Paolo B, Scarselli M, Pozzi C, Tomaszewski K, Galletti B, Nardi-Dei V, Arcidiacono L, Mishra RP, Mori E, Pallaoro M, Falugi F, Torre A, Fontana MR, Soriani M, Bubeck Wardenburg J, Grandi G, Rappuoli R, Ferlenghi I, Bagnoli F (2016) Auto-assembling detoxified Staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin. In: Burns DL (ed) Clin Vaccine Immunol 23:442–450 · DOI
  13. Foletti D, Strop P, Shaughnessy L, Hasa-Moreno A, Casas MG, Russell M, Bee C, Wu S, Pham A, Zeng Z, Pons J, Rajpal A, Shelton D (2013) Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. J Mol Biol 425:1641–1654 · DOI
  14. Guillet V, Roblin P, Werner S, Coraiola M, Menestrina G, Monteil H, Prévost G, Mourey L (2004) Crystal structure of leucotoxin S component: new insight into the Staphylococcal beta-barrel pore-forming toxins. J Biol Chem 279:41028–41037 · DOI · Paper page
  15. Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R, Keller A, O’Day T, Du Q, Cheng L, Damschroder M, Robbie G, Suzich J, Stover CK, Sellman BR (2014) Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 58:1108–1117 · DOI · Paper page
  16. Jayasinghe L, Bayley H (2005) The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis. Protein Sci 14:2550–2561 · DOI
  17. Joubert O, Viero G, Keller D, Martinez E, Colin DA, Monteil H, Mourey L, Dalla Serra M, Prévost G (2006) Engineered covalent leucotoxin heterodimers form functional pores: insights into S–F interactions. Biochem J 396:381–389 · doi:10.1042/bj20051878
  18. Kaneko J, Kamio Y (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68:981–1003 · DOI · Paper page
  19. Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Warfield KL, Shulenin S, Aman MJ (2013) Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model. PLoS One 8:e65384 · DOI
  20. Katsumi H, Tomita T, Kaneko J, Kamio Y (1999) Vitronectin and its fragments purified as serum inhibitors of Staphylococcus aureus gamma-hemolysin and leukocidin, and their specific binding to the hlg2 and the LukS components of the toxins. FEBS Lett 460:451–456 · DOI
  21. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K (2001) Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225–1240 · DOI · Paper page
  22. Laventie BJ, Guérin F, Mourey L, Tawk MY, Jover E, Maveyraud L, Prévost G (2014) Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface. In: Diep BA (ed) PLoS ONE 9:e92094 · DOI
  23. Lewis M, Weaver CD, McClain MS (2010) Identification of small molecule inhibitors of Clostridium perfringens ε-toxin cytotoxicity using a cell-based high-throughput screen. Toxins (Basel) 2:1825–1847 · DOI
  24. Li H, Zhao X, Wang J, Dong Y, Meng S, Li R, Niu X, Deng X (2015) β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection. Sci Rep 5:17668 · doi:10.1038/srep17668
  25. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132 · DOI · Paper page
  26. Löffler B, Hussain M, Grundmeier M, Brück M, Holzinger D, Varga G, Roth J, Kahl BC, Proctor RA, Peters G (2010) Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. In: Cheung A (ed) PLoS Pathog 6:e1000715 · DOI · Paper page
  27. Malachowa N, Kobayashi SD, Braughton KR, Whitney AR, Parnell MJ, Gardner DJ, Deleo FR (2012) Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis 206:1185–1193 · DOI · Paper page
  28. Menestrina G (1986) Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J Membr Biol 90:177–190 · DOI · Paper page
  29. Meyer F, Girardot R, Piemont Y, Prevost G, Colin DA (2009) Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding. Infect Immun 77:266–273 · DOI · Paper page
  30. Monma N, Nguyen VT, Kaneko J, Higuchi H, Kamio Y (2004) Essential residues, W177 and R198, of LukF for phosphatidylcholine-binding and pore-formation by staphylococcal -hemolysin on human erythrocyte membranes. J Biochem 136:427–431 · DOI
  31. Morinaga N, Kaihou Y, Noda M (2003) Purification, cloning and characterization of variant luke-lukd with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol 47:81–90 · DOI · Paper page
  32. Nguyen VT, Kamio Y, Higuchi H (2003) Single-molecule imaging of cooperative assembly of γ-hemolysin on erythrocyte membranes. EMBO J 22:4968–4979 · DOI
  33. Nocadello S, Minasov G, Shuvalova L, Dubrovska I, Sabini E, Bagnoli F, Grandi G, Anderson WF (2016) Crystal structures of the components of the Staphylococcus aureus leukotoxin ED. Acta Cryst D Struct Biol 72:113–120 · DOI
  34. Oganesyan V, Peng L, Damschroder MM, Cheng L, Sadowska A, Tkaczyk C, Sellman BR, Wu H, Dall’Acqua WF (2014) Mechanisms of neutralization of a human anti-alpha toxin antibody. J Biol Chem 289:29874–29880 · DOI · Paper page
  35. Olson R, Nariya H, Yokota K, Kamio Y, Gouaux E (1999) Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat Struct Biol 6:134–140 · DOI
  36. Pédelacq JD, Maveyraud L, Prévost G, Baba-Moussa L, González A, Courcelle E, Shepard W, Monteil H, Samama JP, Mourey L (1999) The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure 7:277–287 · DOI
  37. Potrich C, Bastiani H, Colin DA, Huck S, Prévost G, Dalla Serra M (2009) The influence of membrane lipids in Staphylococcus aureus gamma-hemolysins pore formation. J Membr Biol 227:13–24 · DOI
  38. Qiu J, Niu X, Dong J, Wang D, Wang J, Li H, Luo M, Li S, Feng H, Deng X (2012) Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of -hemolysin. J Infect Dis 206:292–301 · DOI
  39. Ramaro N, Sanchis V (2013) The pore-forming haemolysins of Bacillus cereus: a review. Toxins (Basel) 5:1119–1139 · DOI · Paper page
  40. Reyes-Robles T, Lubkin A, Alonzo F 3rd, Lacy DB, Torres VJ (2016) Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis. EMBO Rep 17:428–440 · DOI
  41. Roblin P, Guillet V, Joubert O, Keller D, Erard M, Maveyraud L, Prévost G, Mourey L (2008) A covalent S-F heterodimer of leucotoxin reveals molecular plasticity of beta-barrel pore-forming toxins. Proteins 71:485–496 · DOI
  42. Rouha H, Badarau A, Visram ZC, Battles MB, Prinz B, Magyarics Z, Nagy G, Mirkina I, Stulik L, Zerbs M, Jägerhofer M, Maierhofer B, Teubenbacher A, Dolezilkova I, Gross K, Banerjee S, Zauner G, Malafa S, Zmajkovic J, Maier S, Mabry R, Krauland E, Wittrup KD, Gerngross TU, Nagy E (2015) Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs 7:243–254 · DOI · Paper page
  43. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE (1996) Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274:1859–1866 · DOI · Paper page
  44. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, Aerts PC, Kemmink J, de Haas CJ, van Kessel KP, Vandenesch F, Lina G, van Strijp JA (2013) The staphylococcal toxin Panton-Valentine leukocidin targets human C5a receptors. Cell Host Microbe 13:584–594 · DOI · Paper page
  45. Spaan AN, Surewaard BG, Nijland R, van Strijp JA (2014a) Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu Rev Microbiol 67:629–650 · DOI · Paper page
  46. Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, Contamin H, Vandenesch F, Lina G, Gerard NP, Gerard C, van Kessel KP, Henry T, van Strijp JA (2014c) Differential interaction of the staphylococcal toxins Panton-Valentine leukocidin and γ-hemolysin CB with human C5a receptors. J Immunol 195:1034–1043 · DOI
  47. Sugawara T, Yamashita D, Kato K, Peng Z, Ueda J, Kaneko J, Kamio Y, Tanaka Y, Yao M (2015) Structural basis for pore-forming mechanism of staphylococcal alpha-hemolysin. Toxicon 108:226–231 · doi:10.1016/j.toxicon.2015.09.033
  48. Tanaka Y, Hirano N, Kaneko J, Kamio Y, Yao M, Tanaka I (2011) 2-Methyl-2,4-pentanediol induces spontaneous assembly of staphylococcal α-hemolysin into heptameric pore structure. Protein Sci 20:448–456 · doi:10.1002/pro.579
  49. Tawk MY, Zimmermann-Meisse G, Bossu JL, Potrich C, Bourcier T, Dalla Serra M, Poulain B, Prévost G, Jover E (2015) Internalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca2+ mobilization by human neutrophils. Cell Microbiol 17:1241–1257 · DOI
  50. von Eiff C, Friedrich AW, Peters G, Becker K (2004) Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 49:157–162 · DOI · Paper page
  51. Wu Q, Guo Z (2010) Glycosylphosphatidylinositols are potential targets for the development of novel inhibitors for aerolysin-type of pore-forming bacterial toxins. Med Res Rev 30:258–269 · doi:10.1002/med.20167
  52. Yamashita K, Kawai Y, Tanaka Y, Hirano N, Kaneko J, Tomita N, Ohta M, Kamio Y, Yao M, Tanaka I (2011) Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components. Proc Natl Acad Sci U S A 108:17314–17319 · DOI · Paper page
  53. Yamashita D, Sugawara T, Takeshita M, Kaneko J, Kamio Y, Tanaka I, Tanaka Y, Yao M (2014) Molecular basis of transmembrane beta-barrel formation of staphylococcal pore-forming toxins. Nat Commun 5:4897 · DOI
  54. Yokota K, Kamio Y (2000) Tyrosine 72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the Staphylococcal γ-Hemolysin to human erythrocytes. Biosci Biotechnol Biochem 64:2744–2747 · doi:10.1271/bbb.64.2744
  55. Yoong P, Torres VJ (2015) Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence. Nat Commun 6:8125 · DOI · Paper page

Cited by

See all 20

Metadata

Authors
Badarau, A., Trstenjak, N., & Nagy, E.
Venue
Advances in Experimental Medicine and Biology
Published
2017
Pages
15-35
ISSN
  • 0065-2598
  • 2214-8019
Cited by
20
References
10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.